AKBA
Akebia Therapeutics, Inc.
NasdaqGM
People also watch:AKAOAERIVSARCNCEAGTC
8.620.02 (0.23%)

After hours: 8.620.00 (0.00%) as of 4:44 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close8.60
Open8.61
Bid7.35 x 200
Ask0.00 x
52wk Range5.91 - 14.20
Day's Range8.47 - 8.84
Volume134,186
Avg Vol (3m)244,569
As of 4:00 PM EDT. Market closed.
  • Akebia Therapeutics, Inc. :AKBA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016
    Capital Cube2 months ago

    Akebia Therapeutics, Inc. :AKBA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016

    Click here to see latest analysisAkebia Therapeutics, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -25.80 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.AKBA-US‘s earnings and EBITDA are […] (Read more...) The post Akebia Therapeutics, Inc. :AKBA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 appeared first on CapitalCube.

  • Associated Press3 months ago

    Akebia Therapeutics reports 1Q loss

    On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 70 cents. Akebia Therapeutics shares have dropped 30 percent since the beginning of the year. In the final minutes ...